Medication info
Ebsimva Tablet 10/10 milligrams

Ebsimva Tablet 10/10 milligrams

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›10mg / 1 tablet
Manufacturer / importer
Korea Pharma Co., Ltd.
Appearance
White to pale yellow, biconvex, rectangular tablet
Packaging
30 tablets (10 tablets/Alu-Alu x 3)
Approval status
Active

MFDS item code 201803737 · Approved 2018.09.17

Summary

Main use
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Administer this medicine once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range of this medicine is 10/10mg~10/40mg once daily. The generally recommended initial dose is 10/20mg once daily. For patients who require a smaller reduction in LDL cholesterol, treatment may be started at 10/10mg once daily. After starting this medicine or adjusting the dose, check blood lipid levels after an interval of 4 weeks or longer and then adjust the dose. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see Warnings, section 1 of Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see Precautions for Use, section 5, General Precautions, Patients with abnormal liver function). Administration to patients with renal impairment and patients with chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer this medicine 10/20mg once daily in the evening. Use caution and carefully monitor these patients when administering higher doses of this medicine (see Precautions for Use, section 5, General Precautions). Administration to elderly patients No dose adjustment is necessary in elderly patients. Concomitant administration with other medicines (See Precautions for Use, section 6, Interactions.) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed a dose of 10/10mg/day. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed a dose of 10/20mg/day.

Ingredients

Manufacturer
Korea Pharma Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerotic vascular diseases due to hypercholesterolemia
View approved original text

This medication helps effectively lower cholesterol and lipid levels in patients with primary hypercholesterolemia and homozygous familial hypercholesterolemia. It is primarily used to reduce LDL cholesterol and total cholesterol, and to increase HDL cholesterol, which reduces the risk of cardiovascular diseases. It is administered in conjunction with dietary control and can be used as an adjunctive treatment for patients who do not respond adequately to other lipid-lowering therapies. This medication is also used as part of a careful treatment plan to manage the risk of atherosclerotic vascular disease in these patients. If necessary, it diagnoses and manages secondary causes to enhance treatment efficacy. This medication is used to improve hypercholesterolemia.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Administer this medicine once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range of this medicine is 10/10mg~10/40mg once daily. The generally recommended initial dose is 10/20mg once daily. For patients who require a smaller reduction in LDL cholesterol, treatment may be started at 10/10mg once daily. After starting this medicine or adjusting the dose, check blood lipid levels after an interval of 4 weeks or longer and then adjust the dose. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see Warnings, section 1 of Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see Precautions for Use, section 5, General Precautions, Patients with abnormal liver function). Administration to patients with renal impairment and patients with chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer this medicine 10/20mg once daily in the evening. Use caution and carefully monitor these patients when administering higher doses of this medicine (see Precautions for Use, section 5, General Precautions). Administration to elderly patients No dose adjustment is necessary in elderly patients. Concomitant administration with other medicines (See Precautions for Use, section 6, Interactions.) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed a dose of 10/10mg/day. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed a dose of 10/20mg/day.

Precautions

This medication is primarily used to lower blood cholesterol levels. Caution is required as muscle pain or weakness may occur when taking this medication. In severe cases, muscle tissue may be damaged, leading to potential kidney problems; if symptoms such as muscle pain or weakness occur, consult a physician immediately. It may affect liver function, so patients with liver diseases or elevated liver enzymes should not take this medication. Furthermore, women who are pregnant or breastfeeding should not use this medication, and women with a possibility of pregnancy should confirm their pregnancy status before use. The risk of muscle-related side effects may increase when taking this medication with specific other drugs, so be sure to inform your doctor or pharmacist if you are taking other medications. Elderly patients over 65 years or those with impaired kidney function require special caution when taking this medication. Regular blood tests to monitor liver function and muscle enzyme levels during treatment are recommended. Additionally, it is advisable to avoid certain foods such as grapefruit juice while taking this medication, and excessive alcohol consumption should be avoided as it can be burdensome to the liver. Patients on this medication should inform any healthcare provider about it when receiving a new prescription and immediately report any symptoms such as muscle pain or other unusual signs.

Side effects

  • Myopathy
  • rhabdomyolysis
  • increased creatine kinase
  • headache
  • diarrhea
  • influenza
  • upper respiratory infection
  • myalgia
  • limb pain
  • fatigue
Show 101 more
  • abdominal pain
  • viral infection
  • pharyngitis
  • sinusitis
  • arthralgia
  • low back pain
  • cough
  • anaphylaxis
  • urticaria
  • rash
  • angioedema
  • elevated liver aminotransferase levels
  • hepatitis
  • thrombocytopenia
  • nausea
  • pancreatitis
  • dizziness
  • sensory disturbances
  • depression
  • cholelithiasis
  • cholecystitis
  • skin and mucous membrane syndrome
  • toxic epidermal necrolysis
  • eosinophilia
  • drug reactions with systemic symptoms
  • erythema multiforme
  • liver damage
  • weakness
  • cataract
  • constipation
  • dyspepsia
  • flatulence
  • nausea
  • eczema
  • pruritus
  • rash
  • muscle cramps
  • immune-mediated necrotizing myopathy
  • specific cranial nerve dysfunction
  • ocular motility disorders
  • facial paresis
  • tremor
  • peripheral neuropathy
  • peripheral nerve paralysis
  • mental disorders
  • anxiety
  • sleep disorders
  • cognitive impairment
  • myasthenia gravis
  • ophthalmoplegia
  • interstitial lung disease
  • lupus erythematosus-like syndrome
  • polymyositis
  • dermatomyositis
  • vasculitis
  • purpura
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibodies
  • increased erythrocyte sedimentation rate
  • arthritis
  • photosensitivity
  • fever
  • chills
  • flushing
  • malaise
  • dyspnea
  • cholestatic jaundice
  • liver fat changes
  • cirrhosis
  • fulminant hepatic necrosis
  • liver cancer
  • alopecia
  • various skin changes
  • lichenoid drug eruption
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • eye muscle paralysis
  • anemia
  • elevated aminotransferases
  • increased ALP
  • increased ɤ-GT
  • elevated bilirubin levels
  • thyroid function abnormalities
  • increased HbA1c
  • elevated fasting blood glucose levels
  • edema
  • thirst
  • facial edema
  • syncope
  • insomnia
  • gastritis
  • atrophic gastritis
  • mucus stools
  • irritable bowel syndrome
  • sore throat
  • nocturia
  • hematuria
  • increased serum creatine phosphokinase
  • weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so the bottle should be tightly closed when stored. It is recommended to keep the storage temperature between 1 to 30 degrees Celsius to maintain the efficacy of the medication for a longer time.

Appearance and packaging

Appearance

White to pale yellow, biconvex, rectangular tablet

Package unit

30 tablets (10 tablets/Alu-Alu x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.